United States Holding Companies

Celularity Inc (CELU)

Track

Celularity Inc. has recorded no insider trading activity within the last 90 days. The most recent transaction occurred on January 12, 2024, involving a purchase of shares by Lim Kok Thay. Prior to this, significant buying and selling activity was observed throughout 2023, primarily involving the Chief Executive Officer and Sorrento Therapeutics, Inc.
Ticker: CELU Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Celularity Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 12 Jan 2024
Value US$2,030,341.33 | Price 274.66 | Shares 81,651 (+13.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-01-17 2024-01-12 B Purchase
3.3
Lim Kok Thay
Large shareholder
81,651 +13.8%
274.66
US$2,030,341 		81,651 +13.8% 274.66 US$2,030,341
2023-10-10 2023-10-05 B Purchase
2.5
Hariri Robert J

Chief Executive Officer

Executive Director
80,177 +3.1%
212.93
US$2,574,534 		80,177 +3.1% 212.93 US$2,574,534
2023-10-10 2023-10-05 B Purchase
2.5
Hariri Robert J

Chief Executive Officer

Executive Director
77,364 -32.7%
35.95
US$4,013,992 		77,364 -32.7% 35.95 US$4,013,992
2023-10-05 2023-10-05 S Sale
Sorrento Therapeutics, Inc.
Large shareholder
6,307,158
0.00
US$0 		6,307,158 0.00 US$0
2023-10-10 2023-09-29 B Purchase
2.5
Hariri Robert J

Chief Executive Officer

Executive Director
9,064,539 +89.3%
0.17
US$1,500,181 		9,064,539 +89.3% 0.17 US$1,500,181
2023-10-05 2023-09-29 S Sale
Sorrento Therapeutics, Inc.
Large shareholder
9,064,539
0.00
US$0 		9,064,539 0.00 US$0
2022-11-30 2022-11-30 B Purchase
2.5
Hariri Robert J

Chief Executive Officer

Executive Director
10,000 +0.1%
1.72
US$17,175 		10,000 +0.1% 1.72 US$17,175
2022-11-29 2022-11-29 B Purchase
2.5
Hariri Robert J

Chief Executive Officer

Executive Director
40,000 +0.5%
1.71
US$68,400 		40,000 +0.5% 1.71 US$68,400
2022-11-28 2022-11-28 B Purchase
2.5
Hariri Robert J

Chief Executive Officer

Executive Director
40,000 +0.5%
1.74
US$69,600 		40,000 +0.5% 1.74 US$69,600
Explore more

More insider trading research around Celularity Inc

More insider trades in United States
Similar Financials companies with insider activity
More Holding Companies companies with insider activity
More Holding Companies companies with insider activity
Insider trading in North America